Search

Your search keyword '"Olivier, Kenneth R."' showing total 347 results
Start Over Author "Olivier, Kenneth R."
347 results on '"Olivier, Kenneth R."'

1. Assessment of minimum target dose as a predictor of local failure after spine SBRT

Author

Kowalchuk, Roman O., Mullikin, Trey C., Spears, Grant M., Johnson-Tesch, Benjamin A., Rose, Peter S., Siontis, Brittany L., Kun Kim, Dong, Costello, Brian A., Morris, Jonathan M., Gao, Robert W., Shiraishi, Satomi, Lucido, John J., Olivier, Kenneth R., Owen, Dawn, Stish, Bradley J., Waddle, Mark R., Laack, Nadia N., Park, Sean S., Brown, Paul D., and Merrell, Kenneth W.

Published
2024
Full Text
View/download PDF

2. Sublobar Resection, Stereotactic Body Radiation Therapy, and Percutaneous Ablation Provide Comparable Outcomes for Lung Metastasis-Directed Therapy

Author

Gits, Hunter C., Khosravi Flanigan, Mitra A., Kapplinger, Jamie D., Reisenauer, Janani S., Eiken, Patrick W., Breen, William G., Vu, Linh H., Welch, Brian T., Harmsen, William S., Day, Courtney N., Olivier, Kenneth R., Park, Sean S., Garces, Yolanda I., Hallemeier, Christopher L., Merrell, Kenneth W., Ashman, Jonathan B., Schild, Steven E., Grams, Michael P., Lucido, J. John, Shen, K. Robert, Cassivi, Stephen D., Wigle, Dennis, Nichols, Francis C., Blackmon, Shanda, Tapias, Luis F., Callstrom, Matthew R., and Owen, Dawn

Published
2024
Full Text
View/download PDF

3. Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer

Author

Yu, Nathan Y., DeWees, Todd A., Voss, Molly M., Breen, William G., Chiang, Jennifer S., Ding, Julia X., Daniels, Thomas B., Owen, Dawn, Olivier, Kenneth R., Garces, Yolanda I., Park, Sean S., Sarkaria, Jann N., Yang, Ping, Savvides, Panayiotis S., Ernani, Vinicius, Liu, Wei, Schild, Steven E., Merrell, Kenneth W., and Sio, Terence T.

Published
2022
Full Text
View/download PDF

5. Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer

Author

Videtic, Gregory M, Paulus, Rebecca, Singh, Anurag K, Chang, Joe Y, Parker, William, Olivier, Kenneth R, Timmerman, Robert D, Komaki, Ritsuko R, Urbanic, James J, Stephans, Kevin L, Yom, Sue S, Robinson, Clifford G, Belani, Chandra P, Iyengar, Puneeth, Ajlouni, Munther I, Gopaul, Darindra D, Gomez Suescun, Jorge B, McGarry, Ronald C, Choy, Hak, and Bradley, Jeffrey D

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Lung, Prevention, Cancer, Lung Cancer, Clinical Research, Clinical Trials and Supportive Activities, 6.5 Radiotherapy and other non-invasive therapies, Evaluation of treatments and therapeutic interventions, Aged, Aged, 80 and over, Carcinoma, Non-Small-Cell Lung, Confidence Intervals, Dose Fractionation, Radiation, Female, Follow-Up Studies, Humans, Lung Neoplasms, Male, Middle Aged, Progression-Free Survival, Radiation Injuries, Radiosurgery, Time Factors, Treatment Failure, Other Physical Sciences, Clinical Sciences, Oncology & Carcinogenesis, Oncology and carcinogenesis, Theoretical and computational chemistry, Medical and biological physics
Abstract

PurposeTo present long-term results of RTOG 0915/NCCTG N0927, a randomized lung stereotactic body radiation therapy trial of 34 Gy in 1 fraction versus 48 Gy in 4 fractions.Methods and materialsThis was a phase 2 multicenter study of patients with medically inoperable non-small cell lung cancer with biopsy-proven peripheral T1 or T2 N0M0 tumors, with 1-year toxicity rates as the primary endpoint and selected failure and survival outcomes as secondary endpoints. The study opened in September 2009 and closed in March 2011. Final data were analyzed through May 17, 2018.ResultsEighty-four of 94 patients accrued were eligible for analysis: 39 in arm 1 and 45 in arm 2. Median follow-up time was 4.0 years for all patients and 6.0 years for those alive at analysis. Rates of grade 3 and higher toxicity were 2.6% in arm 1 and 11.1% in arm 2. Median survival times (in years) for 34 Gy and 48 Gy were 4.1 versus 4.6, respectively. Five-year outcomes (95% confidence interval) for 34 Gy and 48 Gy were a primary tumor failure rate of 10.6% (3.3%-23.1%) versus 6.8% (1.7%-16.9%); overall survival of 29.6% (16.2%-44.4%) versus 41.1% (26.6%-55.1%); and progression-free survival of 19.1% (8.5%-33.0%) versus 33.3% (20.2%-47.0%). Distant failure as the sole failure or a component of first failure occurred in 6 patients (37.5%) in the 34 Gy arm and in 7 (41.2%) in the 48 Gy arm.ConclusionsNo excess in late-appearing toxicity was seen in either arm. Primary tumor control rates at 5 years were similar by arm. A median survival time of 4 years for each arm suggests similar efficacy, pending any larger studies appropriately powered to detect survival differences.

Published
2019

6. Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumab

Author

Gao, Robert W., Day, Courtney N., Yu, Nathan Y., Bush, Aaron, Amundson, Adam C., Prodduturvar, Pranitha, Majeed, Umair, Butts, Emily, Oliver, Thomas, Schwecke, Anna J., Moffett, Jenesse N., Routman, David M., Breen, William G., Potter, Ashley L., Rivera-Concepcion, Joel, Hoppe, Bradford S., Schild, Steven E., Sio, Terence T., Lou, Yanyan, Ernani, Vinicius, Ko, Stephen, Olivier, Kenneth R., Merrell, Kenneth W., Garces, Yolanda I., Manochakian, Rami, Harmsen, William S., Leventakos, Konstantinos, and Owen, Dawn

Published
2022
Full Text
View/download PDF

7. Development and Internal Validation of a Recursive Partitioning Analysis–Based Model Predictive of Pain Flare Incidence After Spine Stereotactic Body Radiation Therapy

Author

Kowalchuk, Roman O., Mullikin, Trey C., Harmsen, William S., Rose, Peter S., Siontis, Brittany L., Kim, Dong Kun, Costello, Brian A., Morris, Jonathan M., Marion, Joseph T., Johnson-Tesch, Benjamin A., Gao, Robert W., Shiraishi, Satomi, Lucido, John J., Olivier, Kenneth R., Owen, Dawn, Stish, Bradley J., Laack, Nadia N., Park, Sean S., Brown, Paul D., and Merrell, Kenneth W.

Published
2022
Full Text
View/download PDF

9. Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate Cancer

Author

Deek, Matthew P., Taparra, Kekoa, Phillips, Ryan, Velho, Pedro Isaacsson, Gao, Robert W., Deville, Curtiland, Song, Daniel Y., Greco, Stephen, Carducci, Michael, Eisenberger, Mario, DeWeese, Theodore L., Denmeade, Samuel, Pienta, Kenneth, Paller, Channing J., Antonarakis, Emmanuel S., Olivier, Kenneth R., Park, Sean S., Tran, Phuoc T., and Stish, Bradley J.

Published
2021
Full Text
View/download PDF

10. Patterns of Recurrence and Modes of Progression After Metastasis-Directed Therapy in Oligometastatic Castration-Sensitive Prostate Cancer

Author

Deek, Matthew P., Taparra, Kekoa, Dao, Dyda, Chan, Luanna, Phillips, Ryan, Gao, Robert W., Kwon, Eugene D., Deville, Curtiland, Song, Daniel Y., Greco, Stephen, Carducci, Michael A., Eisenberger, Mario, DeWeese, Theodore L., Denmeade, Samuel, Pienta, Kenneth, Paller, Channing J., Antonarakis, Emmanuel S., Olivier, Kenneth R., Park, Sean S., Stish, Bradley J., and Tran, Phuoc T.

Published
2021
Full Text
View/download PDF

11. Sublobar Resection, Stereotactic Body Radiation Therapy, and Percutaneous Ablation Provide Comparable Outcomes for Lung Metastasis-Directed Therapy

Author

Gits, Hunter C., primary, Khosravi Flanigan, Mitra A., additional, Kapplinger, Jamie D., additional, Reisenauer, Janani S., additional, Eiken, Patrick W., additional, Breen, William G., additional, Vu, Linh H., additional, Welch, Brian T., additional, Harmsen, William S., additional, Day, Courtney N., additional, Olivier, Kenneth R., additional, Park, Sean S., additional, Garces, Yolanda I., additional, Hallemeier, Christopher L., additional, Merrell, Kenneth W., additional, Ashman, Jonathan B., additional, Schild, Steven E., additional, Grams, Michael P., additional, Lucido, J. John, additional, Shen, K. Robert, additional, Cassivi, Stephen D., additional, Wigle, Dennis, additional, Nichols, Francis C., additional, Blackmon, Shanda, additional, Tapias, Luis F., additional, Callstrom, Matthew R., additional, and Owen, Dawn, additional

Published
2023
Full Text
View/download PDF

12. A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927)

Author

Videtic, Gregory MM, Hu, Chen, Singh, Anurag K, Chang, Joe Y, Parker, William, Olivier, Kenneth R, Schild, Steven E, Komaki, Ritsuko, Urbanic, James J, Timmerman, Robert D, and Choy, Hak

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Cancer, Prevention, Patient Safety, Clinical Research, Lung, Clinical Trials and Supportive Activities, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Accreditation, Adult, Aged, Carcinoma, Non-Small-Cell Lung, Cause of Death, Confidence Intervals, Disease-Free Survival, Dose Fractionation, Radiation, Female, Follow-Up Studies, Humans, Lung Neoplasms, Male, Middle Aged, Neoplasm Staging, Patient Positioning, Radiosurgery, Radiotherapy, Radiotherapy Dosage, Survival Rate, Time Factors, Other Physical Sciences, Oncology & Carcinogenesis, Oncology and carcinogenesis, Theoretical and computational chemistry, Medical and biological physics
Abstract

PurposeTo compare 2 stereotactic body radiation therapy (SBRT) schedules for medically inoperable early-stage lung cancer to determine which produces the lowest rate of grade ≥3 protocol-specified adverse events (psAEs) at 1 year.Methods and materialsPatients with biopsy-proven peripheral (≥2 cm from the central bronchial tree) T1 or T2, N0 (clinically node negative by positron emission tomography), M0 tumors were eligible. Patients were randomized to receive either 34 Gy in 1 fraction (arm 1) or 48 Gy in 4 consecutive daily fractions (arm 2). Rigorous central accreditation and quality assurance confirmed treatment per protocol guidelines. This study was designed to detect a psAEs rate >17% at a 10% significance level (1-sided) and 90% power. Secondary endpoints included rates of primary tumor control (PC), overall survival (OS), and disease-free survival (DFS) at 1 year. Designating the better of the 2 regimens was based on prespecified rules of psAEs and PC for each arm.ResultsNinety-four patients were accrued between September 2009 and March 2011. The median follow-up time was 30.2 months. Of 84 analyzable patients, 39 were in arm 1 and 45 in arm 2. Patient and tumor characteristics were balanced between arms. Four (10.3%) patients on arm 1 (95% confidence interval [CI] 2.9%-24.2%) and 6 (13.3%) patients on arm 2 (95% CI 5.1%-26.8%) experienced psAEs. The 2-year OS rate was 61.3% (95% CI 44.2%-74.6%) for arm 1 patients and 77.7% (95% CI 62.5%-87.3%) for arm 2. The 2-year DFS was 56.4% (95% CI 39.6%-70.2%) for arm 1 and 71.1% (95% CI 55.5%-82.1%) for arm 2. The 1-year PC rate was 97.0% (95% CI 84.2%-99.9%) for arm 1 and 92.7% (95% CI 80.1%-98.5%) for arm 2.Conclusions34 Gy in 1 fraction met the prespecified criteria and, of the 2 schedules, warrants further clinical research.

Published
2015

17. Society for Women in Radiation Oncology Consensus Statement on Family and Medical Leave

Author

Baniel, Claire Christine, primary, Ponce, Sara Beltrán, additional, Lichter, Katie E., additional, Peters, Gabrielle W., additional, Small, Christina, additional, Seldon, Crystal, additional, Nguyen, Katarina T., additional, Khan, Amanda Farah, additional, Thomas, Charles R., additional, Small, William, additional, Kahn, Jenna M., additional, Olivier, Kenneth R., additional, Masters, Adrianna Henson, additional, Barry, Parul N., additional, Pollom, Erqi L., additional, and Jagsi, Reshma, additional

Published
2023
Full Text
View/download PDF

21. Data from PD-1 Restrains Radiotherapy-Induced Abscopal Effect

Author

Park, Sean S., primary, Dong, Haidong, primary, Liu, Xin, primary, Harrington, Susan M., primary, Krco, Christopher J., primary, Grams, Michael P., primary, Mansfield, Aaron S., primary, Furutani, Keith M., primary, Olivier, Kenneth R., primary, and Kwon, Eugene D., primary

Published
2023
Full Text
View/download PDF

22. Supplementary Table 1 from Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in 11C-Choline-PET/CT–Identified Oligometastatic Castration-Resistant Prostate Cancer

Author

Zhang, Henan, primary, Orme, Jacob J., primary, Abraha, Feven, primary, Stish, B.J., primary, Lowe, Val J., primary, Lucien, Fabrice, primary, Tryggestad, Erik J., primary, Bold, Michael S., primary, Pagliaro, Lance C., primary, Choo, C. Richard, primary, Brinkmann, Debra H., primary, Iott, Matthew J., primary, Davis, Brian J., primary, Quevedo, J. Fernando, primary, Harmsen, William S., primary, Costello, Brian A., primary, Johnson, Geoffrey B., primary, Nathan, Mark A., primary, Olivier, Kenneth R., primary, Pisansky, Thomas M., primary, Kwon, Eugene D., primary, Dong, Haidong, primary, and Park, Sean S., primary

Published
2023
Full Text
View/download PDF

23. Supplementary Figure 1 from Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in 11C-Choline-PET/CT–Identified Oligometastatic Castration-Resistant Prostate Cancer

Author

Zhang, Henan, primary, Orme, Jacob J., primary, Abraha, Feven, primary, Stish, B.J., primary, Lowe, Val J., primary, Lucien, Fabrice, primary, Tryggestad, Erik J., primary, Bold, Michael S., primary, Pagliaro, Lance C., primary, Choo, C. Richard, primary, Brinkmann, Debra H., primary, Iott, Matthew J., primary, Davis, Brian J., primary, Quevedo, J. Fernando, primary, Harmsen, William S., primary, Costello, Brian A., primary, Johnson, Geoffrey B., primary, Nathan, Mark A., primary, Olivier, Kenneth R., primary, Pisansky, Thomas M., primary, Kwon, Eugene D., primary, Dong, Haidong, primary, and Park, Sean S., primary

Published
2023
Full Text
View/download PDF

24. Supplementary Figure 3 from Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in 11C-Choline-PET/CT–Identified Oligometastatic Castration-Resistant Prostate Cancer

Author

Zhang, Henan, primary, Orme, Jacob J., primary, Abraha, Feven, primary, Stish, B.J., primary, Lowe, Val J., primary, Lucien, Fabrice, primary, Tryggestad, Erik J., primary, Bold, Michael S., primary, Pagliaro, Lance C., primary, Choo, C. Richard, primary, Brinkmann, Debra H., primary, Iott, Matthew J., primary, Davis, Brian J., primary, Quevedo, J. Fernando, primary, Harmsen, William S., primary, Costello, Brian A., primary, Johnson, Geoffrey B., primary, Nathan, Mark A., primary, Olivier, Kenneth R., primary, Pisansky, Thomas M., primary, Kwon, Eugene D., primary, Dong, Haidong, primary, and Park, Sean S., primary

Published
2023
Full Text
View/download PDF

25. Supplementary Table 2 from Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in 11C-Choline-PET/CT–Identified Oligometastatic Castration-Resistant Prostate Cancer

Author

Zhang, Henan, primary, Orme, Jacob J., primary, Abraha, Feven, primary, Stish, B.J., primary, Lowe, Val J., primary, Lucien, Fabrice, primary, Tryggestad, Erik J., primary, Bold, Michael S., primary, Pagliaro, Lance C., primary, Choo, C. Richard, primary, Brinkmann, Debra H., primary, Iott, Matthew J., primary, Davis, Brian J., primary, Quevedo, J. Fernando, primary, Harmsen, William S., primary, Costello, Brian A., primary, Johnson, Geoffrey B., primary, Nathan, Mark A., primary, Olivier, Kenneth R., primary, Pisansky, Thomas M., primary, Kwon, Eugene D., primary, Dong, Haidong, primary, and Park, Sean S., primary

Published
2023
Full Text
View/download PDF

26. Development and validation of a unifying pre-treatment decision tool for intracranial and extracranial metastasis-directed radiotherapy

Author

Kowalchuk, Roman, primary, Mullikin, Trey C., additional, Breen, William, additional, Gits, Hunter C., additional, Florez, Marcus, additional, De, Brian, additional, Harmsen, William S., additional, Rose, Peter Sean, additional, Siontis, Brittany L., additional, Costello, Brian A., additional, Morris, Jonathan M., additional, Lucido, John J., additional, Olivier, Kenneth R., additional, Stish, Brad, additional, Laack, Nadia N., additional, Park, Sean, additional, Owen, Dawn, additional, Ghia, Amol J., additional, Brown, Paul D., additional, and Merrell, Kenneth Wing, additional

Published
2023
Full Text
View/download PDF

27. Establishment of practice standards in nomenclature and prescription to enable construction of software and databases for knowledge-based practice review

Author

Mayo, Charles S., Pisansky, Thomas M., Petersen, Ivy A., Yan, Elizabeth S., Davis, Brian J., Stafford, Scott L., Garces, Yolanda I., Miller, Robert C., Martenson, James A., Mutter, Robert W., Choo, Richard, Hallemeier, Christopher L., Laack, Nadia N., Park, Sean S., Ma, Daniel J., Olivier, Kenneth R., Keole, Sameer R., Fatyga, Mirek, Foote, Robert L., and Haddock, Michael G.

Published
2016
Full Text
View/download PDF

32. Development and validation of a recursive partitioning analysis–based pretreatment decision‐making tool identifying ideal candidates for spine stereotactic body radiation therapy

Author

Kowalchuk, Roman O., primary, Mullikin, Trey C., additional, Florez, Marcus, additional, De, Brian S., additional, Spears, Grant M., additional, Rose, Peter S., additional, Siontis, Brittany L., additional, Kim, Dong Kun, additional, Costello, Brian A., additional, Morris, Jonathan M., additional, Marion, Joseph T., additional, Johnson‐Tesch, Benjamin A., additional, Gao, Robert W., additional, Shiraishi, Satomi, additional, Lucido, John J., additional, Trifiletti, Daniel M., additional, Olivier, Kenneth R., additional, Owen, Dawn, additional, Stish, Bradley J., additional, Waddle, Mark R., additional, Laack, Nadia N., additional, Park, Sean S., additional, Brown, Paul D., additional, Ghia, Amol J., additional, and Merrell, Kenneth W., additional

Published
2022
Full Text
View/download PDF

33. Single and Multifraction Spine Stereotactic Body Radiation Therapy and the Risk of Radiation Induced Myelopathy

Author

Lucido, J. John, primary, Mullikin, Trey C., additional, Abraha, Feven, additional, Harmsen, W. Scott, additional, Vaishnav, Birjoo D., additional, Brinkmann, Debra H., additional, Kowalchuk, Roman O., additional, Marion, Joseph T., additional, Johnson-Tesch, Benjamin A., additional, El Sherif, Omar, additional, Brown, Paul D., additional, Rose, Peter S., additional, Owen, Dawn, additional, Morris, Jonathan M., additional, Waddle, Mark R., additional, Siontis, Brittany L., additional, Stish, Bradley J., additional, Pafundi, Deanna H., additional, Laack, Nadia N., additional, Olivier, Kenneth R., additional, Park, Sean S., additional, and Merrell, Kenneth W., additional

Published
2022
Full Text
View/download PDF

43. Stereotactic Body Radiation Therapy for Metastases in Long Bones

Author

MS Radiotherapie, Cancer, Klinische Fysica RT, Madani, Indira, Sahgal, Arjun, Erler, Darby, Stish, Bradley J., Olivier, Kenneth R., Park, Sean S., Eppinga, W. S.C., Seravalli, Enrica, Redmond, Kristin J., Cao, Yilin, Siva, Shankar, Chang, David, Nguyen, Timothy K., O'Neil, Melissa, Guckenberger, Matthias, MS Radiotherapie, Cancer, Klinische Fysica RT, Madani, Indira, Sahgal, Arjun, Erler, Darby, Stish, Bradley J., Olivier, Kenneth R., Park, Sean S., Eppinga, W. S.C., Seravalli, Enrica, Redmond, Kristin J., Cao, Yilin, Siva, Shankar, Chang, David, Nguyen, Timothy K., O'Neil, Melissa, and Guckenberger, Matthias

Published
2022

44. Development and validation of a recursive partitioning analysis–based pretreatment decision‐making tool identifying ideal candidates for spine stereotactic body radiation therapy.

Author

Kowalchuk, Roman O., Mullikin, Trey C., Florez, Marcus, De, Brian S., Spears, Grant M., Rose, Peter S., Siontis, Brittany L., Kim, Dong Kun, Costello, Brian A., Morris, Jonathan M., Marion, Joseph T., Johnson‐Tesch, Benjamin A., Gao, Robert W., Shiraishi, Satomi, Lucido, John J., Trifiletti, Daniel M., Olivier, Kenneth R., Owen, Dawn, Stish, Bradley J., and Waddle, Mark R.

Subjects
STEREOTACTIC radiotherapy, RECURSIVE partitioning, SPINE, SPINAL instability, DECISION making
Abstract

Background: This study was aimed at developing and validating a decision‐making tool predictive of overall survival (OS) for patients receiving stereotactic body radiation therapy (SBRT) for spinal metastases. Methods: Three hundred sixty‐one patients at one institution were used for the training set, and 182 at a second institution were used for external validation. Treatments most commonly involved one or three fractions of spine SBRT. Exclusion criteria included proton therapy and benign histologies. Results: The final model consisted of the following variables and scores: Spinal Instability Neoplastic Score (SINS) ≥ 6 (1), time from primary diagnosis < 21 months (1), Eastern Cooperative Oncology Group (ECOG) performance status = 1 (1) or ECOG performance status > 1 (2), and >1 organ system involved (1). Each variable was an independent predictor of OS (p <.001), and each 1‐point increase in the score was associated with a hazard ratio of 2.01 (95% confidence interval [CI], 1.79–2.25; p <.0001). The concordance value was 0.75 (95% CI, 0.71–0.78). The scores were discretized into three groups—favorable (score = 0–1), intermediate (score = 2), and poor survival (score = 3–5)—with 2‐year OS rates of 84% (95% CI, 79%–90%), 46% (95% CI, 36%–59%), and 21% (95% CI, 14%–32%), respectively (p <.0001 for each). In the external validation set (182 patients), the score was also predictive of OS (p <.0001). Increasing SINS was predictive of decreased OS as a continuous variable (p <.0001). Conclusions: This novel score is proposed as a decision‐making tool to help to optimize patient selection for spine SBRT. SINS may be an independent predictor of OS. A model predictive of overall survival after spine stereotactic body radiation therapy (SBRT) has been developed and externally validated, and it provides a decision‐making tool to help to optimize patient selection for spine SBRT. The model components are the Spinal Instability Neoplastic Score, the time from diagnosis, the performance status, and the organ systems involved. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

46. Development and Assessment of a Predictive Score for Vertebral Compression Fracture After Stereotactic Body Radiation Therapy for Spinal Metastases

Author

Kowalchuk, Roman O., primary, Johnson-Tesch, Benjamin A., additional, Marion, Joseph T., additional, Mullikin, Trey C., additional, Harmsen, William S., additional, Rose, Peter S., additional, Siontis, Brittany L., additional, Kim, Dong Kun, additional, Costello, Brian A., additional, Morris, Jonathan M., additional, Gao, Robert W., additional, Shiraishi, Satomi, additional, Lucido, John J., additional, Sio, Terence T., additional, Trifiletti, Daniel M., additional, Olivier, Kenneth R., additional, Owen, Dawn, additional, Stish, Bradley J., additional, Waddle, Mark R., additional, Laack, Nadia N., additional, Park, Sean S., additional, Brown, Paul D., additional, and Merrell, Kenneth W., additional

Published
2022
Full Text
View/download PDF

48. Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in 11C-Choline-PET/CT–Identified Oligometastatic Castration-Resistant Prostate Cancer

Author

Zhang, Henan, primary, Orme, Jacob J., additional, Abraha, Feven, additional, Stish, B.J., additional, Lowe, Val J., additional, Lucien, Fabrice, additional, Tryggestad, Erik J., additional, Bold, Michael S., additional, Pagliaro, Lance C., additional, Choo, C. Richard, additional, Brinkmann, Debra H., additional, Iott, Matthew J., additional, Davis, Brian J., additional, Quevedo, J. Fernando, additional, Harmsen, William S., additional, Costello, Brian A., additional, Johnson, Geoffrey B., additional, Nathan, Mark A., additional, Olivier, Kenneth R., additional, Pisansky, Thomas M., additional, Kwon, Eugene D., additional, Dong, Haidong, additional, and Park, Sean S., additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results